Adele Salim

Adele Salim serves as a procurement specialist within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical biomedical and laboratory capabilities. She manages a diverse portfolio of contracts focused on enabling infectious disease detection, diagnostic innovation, and data-driven public health operations. Her work centers on securing high-complexity scientific equipment, biotechnology research services, and analytical laboratory systems essential for national surveillance and emergency response. Salim ensures procurement activities align with federal regulations and CDC’s scientific priorities, facilitating timely access to mission-critical resources across federal, state, and local public health networks. She maintains enduring partnerships with leading providers in the life sciences and diagnostics sectors, including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid. These relationships reflect a pattern of engagement with established industry leaders capable of delivering high-assurance biological products, advanced analytical instruments, and scalable research infrastructure. Her contracting approach emphasizes technical rigor, compliance with biosafety standards, and supply chain resilience, often requiring complex solicitation strategies for specialized scientific capabilities not readily available in the commercial marketplace. Salim’s procurement portfolio reflects a strong preference for full and open competition, with no set-asides applied to her awarded contracts. This indicates a focus on securing the highest technical capability and operational scale, prioritizing mission effectiveness over socioeconomic targeting. While small business participation is not formally prioritized in her portfolio, her contracting practices remain fully compliant with all federal socioeconomic requirements, ensuring transparency and fairness in all procurement actions. Her primary procurement focus lies in NAICS 325414 (Biological Product Manufacturing), 541714 (Biotechnology R&D), and 334516 (Analytical Laboratory Instrument Manufacturing), reflecting deep expertise in procuring diagnostic reagents, molecular testing platforms, and laboratory automation systems. She routinely engages with vendors offering next-generation sequencing infrastructure, real-time pathogen detection technologies, and high-throughput data processing services essential for modern public health laboratories.